Medopharm Private Limited — Amoxicillin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Amoxicillin · $7.3M export value · DGFT Verified
Medopharm Private Limited is the #9 Indian exporter of Amoxicillin with $7.3M in export value and 145 verified shipments. Medopharm Private Limited holds a 1.2% market share in Amoxicillin exports across 16 countries. The company exports 6 pharmaceutical products worth $8.9M across 3 therapeutic categories.
Medopharm Private Limited — Amoxicillin Export Profile: Buyers & Destinations
Where Does Medopharm Private Limited Export Amoxicillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $859.5K | 55 | 18.0% |
| PERU | $696.2K | 34 | 14.6% |
| TANZANIA | $400.0K | 8 | 8.4% |
| NICARAGUA | $352.3K | 14 | 7.4% |
| MYANMAR | $349.0K | 12 | 7.3% |
| VIETNAM, DEMOCRATIC REP. OF | $331.8K | 7 | 7.0% |
| GERMANY | $270.9K | 24 | 5.7% |
| FRANCE | $166.8K | 13 | 3.5% |
| GAUTEMALA | $150.0K | 3 | 3.1% |
| DOMINICAN REPULIC | $147.5K | 25 | 3.1% |
Medopharm Private Limited exports Amoxicillin to 31 countries. The largest destination is ETHIOPIA accounting for 18.0% of Medopharm Private Limited's Amoxicillin shipments, followed by PERU (14.6%) and TANZANIA (8.4%). These destinations reflect Medopharm Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amoxicillin from Medopharm Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SEVEN PHARMA NICARAGUA S.A | NICARAGUA | $270.4K | 8 |
| LWIN AND MYINT TRADING CO. LTD. | MYANMAR | $199.7K | 8 |
| MAF PHARMA FOR PHARMACEUTICAL | YEMEN DEMOCRATIC | $192.8K | 8 |
| M/S. KARE PHARMACEUTICALS PLC | ETHIOPIA | $191.7K | 10 |
| M/S. SHERFARMA SAC | PERU | $176.6K | 5 |
| PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $173.9K | 26 |
| PHILCO PHARMA E K | GERMANY | $169.5K | 19 |
| MEDICAL STORES DEPARTMENT. | TANZANIA | $150.0K | 3 |
| M/S. CAMEG | BURKINA FASO | $137.0K | 3 |
| KARE PHARMACEUTICALS PLC. | ETHIOPIA | $135.4K | 15 |
Medopharm Private Limited supplies Amoxicillin to 75 buyers globally. The largest buyer is SEVEN PHARMA NICARAGUA S.A (NICARAGUA), followed by LWIN AND MYINT TRADING CO. LTD. (MYANMAR) and MAF PHARMA FOR PHARMACEUTICAL (YEMEN DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amoxicillin Export Value and How Much Does Medopharm Private Limited Contribute?
India exported $328.2M worth of Amoxicillin through 15,000 shipments from 633 suppliers to 161 countries, serving 2,055 buyers globally. Medopharm Private Limited contributes $7.3M to this total, accounting for 1.2% of India's Amoxicillin exports. Medopharm Private Limited ships Amoxicillin to 31 countries through 75 buyers.
What Is the Average Shipment Value for Medopharm Private Limited's Amoxicillin Exports?
Medopharm Private Limited's average Amoxicillin shipment value is $50.0K per consignment, based on 145 shipments totaling $7.3M. The largest destination is ETHIOPIA (18.0% of Medopharm Private Limited's Amoxicillin exports).
How Does Medopharm Private Limited Compare to Other Indian Amoxicillin Exporters?
Medopharm Private Limited ranks #9 among 633 Indian Amoxicillin exporters with a 1.2% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($96.1M), MICRO LABS LIMITED ($63.3M), MEDREICH LIMITED ($47.7M). Medopharm Private Limited processed 145 shipments to 16 destination countries.
What Amoxicillin Formulations Does Medopharm Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULES | $198.1K | 8 |
| MEDOMOX 250 DT (AMOXICILLIN TABLETS FOR | $150.0K | 3 |
| AP CLAV 625 (AMOXICILLIN 500MG+CLAVULANI | $150.0K | 3 |
| AMOXICILLIN ORAL SUSPENSION BP 250MG/5ML | $137.6K | 5 |
| AMOXICILLIN TABLETS ORAL SUSPENSION USP | $137.0K | 3 |
| AMOXILIP 250 (AMOXICILLIN ORAL SUSPENSIO | $126.6K | 5 |
| AMOXI ORAL (AMOXICILLIN ORAL SUSPENSION | $111.2K | 3 |
| MEDOMOX 250 (AMOXICILLIN ORAL SUSPENSION | $102.2K | 5 |
| AMOXYSEVEN 625 (AMOXICILLIN 500MG+ CLAVU | $100.0K | 2 |
| MEDOMOX 250 AMOXICILLIN ORAL SUSPENSION | $99.9K | 2 |
Medopharm Private Limited exports 162 distinct Amoxicillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMOXICILLIN AND FLUCLOXACILLIN CAPSULES with 8 shipments worth $198.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Medopharm Private Limited Compare to Nearest Amoxicillin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | UNICHEM LABORATORIES LIMITED | $10.3M | 408 | 11 | $25.4K |
| 6 | MEDOPHARM | $7.3M | 147 | 24 | $50.0K |
| 9 | MEDOPHARM PRIVATE LIMITED ★ | $7.3M | 145 | 16 | $50.0K |
| 11 | SPARSH BIO-TECH PRIVATE LIMITED | $6.5M | 183 | 13 | $35.6K |
| 14 | MEDICO REMEDIES LIMITED | $5.3M | 108 | 13 | $48.7K |
Medopharm Private Limited ranks #9 among 633 Indian Amoxicillin exporters. Average shipment value of $50.0K compared to the market average of $518.4K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and MEDOPHARM.
Which Indian Ports Ship Amoxicillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,157 | 7.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,133 | 7.6% |
| HYDERABAD ICD (INSNF6) | 926 | 6.2% |
| HYDERABAD ICD | 797 | 5.3% |
| BANGALORE ICD (INWFD6) | 717 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 695 | 4.6% |
| SAHAR AIR | 483 | 3.2% |
| BANGALORE ICD | 471 | 3.1% |
What Other Antibiotics Products Does Medopharm Private Limited Export?
Medopharm Private Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm Private Limited's Amoxicillin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges,' adding financial strain to exporters relying on these routes. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate delays and cost escalations.
Conversely, the India–European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable outlook. The FTA eliminates tariffs on Indian pharmaceutical exports to the EU, potentially enhancing market access and competitiveness for companies like Medopharm. This development aligns with India's broader strategy to diversify export destinations and reduce dependency on the US market, especially in light of potential tariff impositions by the US on pharmaceutical imports.
Medopharm Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent Good Manufacturing Practice (GMP) requirements. Historically, non-compliance has led to import bans and reputational damage for Indian firms. Therefore, maintaining adherence to these standards is critical for market access and sustained growth.
While specific regulatory events concerning Medopharm are not reported, the company must continuously invest in quality assurance and regulatory compliance to navigate the evolving landscape. The India–EU FTA also emphasizes the need for Indian exporters to meet the EU's rigorous standards, necessitating ongoing vigilance and adaptation.
About Medopharm Private Limited
Medopharm Private Limited exports 6 products worth $8.9M. Beyond Amoxicillin, top products include Erythromycin, Flucloxacillin, Pyrimethamine, Sulfadoxine, Praziquantel. View the complete Medopharm Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amoxicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amoxicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 257 individual customs records matching Medopharm Private Limited exporting Amoxicillin, covering 162 formulations to 31 countries via 75 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 161+ countries, 2,055+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amoxicillin Export Data from Medopharm Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm Private Limited's Amoxicillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm Private Limited
Full Company Profile →
6 products · $8.9M total trade · 3 categories
Amoxicillin Stats
Company Overview
Top Products by Medopharm Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amoxicillin. For current shipment-level data, contact TransData Nexus.